Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$737M |
| 2 |
American Tower
AMT
|
+$687M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$554M |
| 4 |
Abbott
ABT
|
+$553M |
| 5 |
SLB Ltd
SLB
|
+$449M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$1.06B |
| 2 |
Netflix
NFLX
|
+$816M |
| 3 |
Match Group
MTCH
|
+$678M |
| 4 |
NVIDIA
NVDA
|
+$611M |
| 5 |
Intuitive Surgical
ISRG
|
+$530M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.17% |
| 2 | Consumer Discretionary | 21.87% |
| 3 | Healthcare | 15.92% |
| 4 | Financials | 9.87% |
| 5 | Communication Services | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Prestige Consumer Healthcare
PBH
$2.38B
| $26.5M | 0.03% |
450,067
+9,046
| +2% | +$499K |
|
277
Arista Networks
ANET
$227B
| $26.4M | 0.03% |
1,125,884
+746,472
| +197% | +$20.5M |
|
|
AESC
278
DELISTED
The AES Corporation
AESC
| $26.4M | 0.03% |
305,484
| – | – |
|
279
Texas Roadhouse
TXRH
$13.5B
| $26.2M | 0.03% |
357,694
-16,059
| -4% | -$1.26M |
|
280
Coupang
CPNG
$29.3B
| $26M | 0.03% |
2,040,981
+754,749
| +59% | +$10.3M |
|
281
Entegris
ENTG
$18.1B
| $25.8M | 0.03% |
280,163
-20,768
| -7% | -$2.25M |
|
282
Martin Marietta Materials
MLM
$31.5B
| $25.4M | 0.03% |
85,007
+13,843
| +19% | +$4.72M |
|
283
MACOM Technology Solutions
MTSI
$19.2B
| $25.1M | 0.03% |
545,232
-116,710
| -18% | -$6.02M |
|
284
Gates Industrial Corporation Ltd.
GTES
$7.08B
| $25.1M | 0.03% |
2,322,442
-809,393
| -26% | -$10.1M |
|
285
PagerDuty
PD
$816M
| $25M | 0.02% |
1,008,367
-246,966
| -20% | -$6.78M |
|
286
Toll Brothers
TOL
$13.6B
| $24.9M | 0.02% |
558,859
-20,865
| -4% | -$976K |
|
287
Steris
STE
$22.3B
| $24.7M | 0.02% |
119,894
-18,167
| -13% | -$4.1M |
|
|
RVNC
288
DELISTED
Revance Therapeutics, Inc.
RVNC
| $24.3M | 0.02% |
1,755,703
-685,583
| -28% | -$10.6M |
|
289
Pacira BioSciences
PCRX
$1.04B
| $24.2M | 0.02% |
+414,371
| New | +$27.1M |
|
290
Freshpet
FRPT
$2.93B
| $24M | 0.02% |
461,839
+65,082
| +16% | +$5.02M |
|
291
EQT Corp
EQT
$33.3B
| $23.8M | 0.02% |
690,958
-348,775
| -34% | -$14.4M |
|
292
Clear Secure
YOU
$5.57B
| $23.7M | 0.02% |
1,186,080
-17,831
| -1% | -$481K |
|
|
BRKL
293
DELISTED
Brookline Bancorp
BRKL
| $23.7M | 0.02% |
1,779,434
+108,553
| +6% | +$1.56M |
|
294
Datadog
DDOG
$95.4B
| $23.6M | 0.02% |
247,414
+241,936
| +4,417% | +$26.6M |
|
295
Pembina Pipeline
PBA
$28.4B
| $23.5M | 0.02% |
664,962
-7,883
| -1% | -$304K |
|
296
Wabtec
WAB
$49.1B
| $23.1M | 0.02% |
281,977
-2,759
| -1% | -$246K |
|
297
Enterprise Products Partners
EPD
$82.3B
| $23M | 0.02% |
944,403
-21,319
| -2% | -$561K |
|
298
XPeng
XPEV
$12.4B
| $22.9M | 0.02% |
721,258
-741,793
| -51% | -$19.1M |
|
299
Delta Air Lines
DAL
$57.5B
| $22.9M | 0.02% |
789,143
+42,339
| +6% | +$1.61M |
|
|
FFWM
300
DELISTED
First Foundation Inc
FFWM
| $22.5M | 0.02% |
1,099,329
+42,836
| +4% | +$948K |
|
Similar funds
Jennison Associates's Q2 2022 Portfolio in Review
As of Q2 2022, Jennison Associates held 720 positions worth $100B, down 26% from $136B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Jennison Associates withdrew a net $3.7B in Q2 2022, closing 106 positions and reducing 265 holdings. Its most notable exit was Okta, an estimated $272M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in KBR worth $40.4M.
- Jennison Associates's largest Q2 2022 buy was KBR: 834,334 shares worth $40.4M.
- Jennison Associates added most to Eli Lilly in Q2 2022, an estimated $737M increase.
- Jennison Associates's biggest Q2 2022 reduction was Shopify, cutting an estimated $1.06B.
- Jennison Associates fully exited Okta in Q2 2022, selling an estimated $272M.
- Jennison Associates's ten largest holdings make up 41% of its $100B portfolio in Q2 2022.
- Jennison Associates opened 95 new positions and closed 106 in Q2 2022.
- Jennison Associates's portfolio value fell 26% quarter-over-quarter to $100B.
Based on Jennison Associates's 13F filing for Q2 2022, filed 2 Aug 2022.